ENTERO

Entero Healthcare Solutions Share Price

₹1,315.65 +15 (1.15%)

22 Feb, 2025 23:04

SIP TrendupStart SIP in ENTERO

Start SIP

Performance

  • Low
  • ₹1,282
  • High
  • ₹1,349
  • 52 Week Low
  • ₹970
  • 52 Week High
  • ₹1,584
  • Open Price₹1,305
  • Previous Close₹1,301
  • Volume45,058

Investment Returns

  • Over 1 Month + 0.5%
  • Over 3 Month + 0.84%
  • Over 6 Month + 0.81%
  • Over 1 Year + 12.78%
SIP Lightning

Smart Investing Starts Here Start SIP with Entero Healthcare Solutions for Steady Growth!

Invest Now

Entero Healthcare Solutions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 63.5
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 5,722
  • P/B Ratio
  • 3.4
  • Average True Range
  • 68.11
  • EPS
  • 20.71
  • Dividend Yield
  • 0
  • MACD Signal
  • -20.34
  • RSI
  • 46.66
  • MFI
  • 53.06

Entero Healthcare Solutions Financials

Entero Healthcare Solutions Technicals

EMA & SMA

Current Price
₹1,315.65
+ 15 (1.15%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹1,330.92
  • 50 Day
  • ₹1,359.70
  • 100 Day
  • ₹1,354.04
  • 200 Day
  • ₹1,274.10

Resistance and Support

1315.57 Pivot Speed
  • R3 1,416.18
  • R2 1,382.62
  • R1 1,349.13
  • S1 1,282.08
  • S2 1,248.52
  • S3 1,215.03

What's your outlook on Entero Healthcare Solutions?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Entero Healthcare Solutions is a leading supply chain and distribution company in India, specializing in pharmaceuticals, medical devices, and healthcare products. It provides end-to-end logistics services, connecting manufacturers with pharmacies, hospitals, and healthcare providers nationwide.

Entero Healthcare Solutions Ltd has an operating revenue of Rs. 4,790.90 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Entero Healthcare Solutions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-12 Quarterly Results
2024-11-12 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-03-08 Quarterly Results

Entero Healthcare Solutions F&O

Entero Healthcare Solutions Shareholding Pattern

52.44%
5.29%
0.78%
22.2%
4.36%
14.93%

About Entero Healthcare Solutions

  • NSE Symbol
  • ENTERO
  • BSE Symbol
  • 544122
  • Managing Director & CEO
  • Mr. Prabhat Agrawal
  • ISIN
  • INE010601016

Similar Stocks to Entero Healthcare Solutions

Entero Healthcare Solutions FAQs

Entero Healthcare Solutions share price is ₹1,315 As on 22 February, 2025 | 22:50

The Market Cap of Entero Healthcare Solutions is ₹5722.3 Cr As on 22 February, 2025 | 22:50

The P/E ratio of Entero Healthcare Solutions is 63.5 As on 22 February, 2025 | 22:50

The PB ratio of Entero Healthcare Solutions is 3.4 As on 22 February, 2025 | 22:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23